SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Chen PC, Wu CS, Chang-Chien SC, Liaw YF. Comparison of Olympus GIF-P2 and GIF-K panendoscopy. Taiwan I Hsueh Hui Tsa Chih 1979; 78: 136 40.
  • 2
    Yeh C, Hsu CT, Ho AS, Sampliner RE, Fass R. Erosive esophagitis and Barrett’s esophagus in Taiwan: A higher frequency than expected. Dig. Dis. Sci. 1997; 42: 702 6.
  • 3
    Dent J, Holloway RH, Toouli J, Dodds WJ. Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastro-oesophageal reflux. Gut 1988; 29: 1020 8.
  • 4
    Spechler SJ. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 1992; 51 (Suppl. 1): 24 9.
  • 5
    Tytgat GNJ, Janssens J, Reynolds JC, Wienbeck M. Update on the pathophysiology and management of gastro-oesophageal reflux disease: The role of prokinetic therapy. Eur. J. Gastroenterol. Hepatol. 1996; 8: 603 11.
  • 6
    Cunningham KM, Horowitz M, Riddell PS et al. Relations among autonomic nerve dysfunction, oesophageal motility, and gastric emptying in gastro-oesophageal reflux disease. Gut 1991; 32: 1436 40.
  • 7
    Petersen H, Johannessen T, Sandvik AK et al. Relationship between endoscopic hiatus hernia and gastroesophageal reflux symptoms. Scand. J. Gastroenterol. 1991; 26: 921 6.
  • 8
    Berstad A, Weberg R, Froyshov Larsen I, Hoel B, Hauer-Jensen M. Relationship of hiatus hernia to reflux oesophagitis. A prospective study of coincidence, using endoscopy. Scand. J. Gastroenterol. 1986; 21: 55 8.
  • 9
    Wright RA & Hurwitz AL. Relationship of hiatal hernia to endoscopically proved reflux esophagitis. Dig. Dis. Sci. 1979; 24: 311 13.
  • 10
    Koster ED. Adverse events of HP eradication: Long-term negative consequences of HP eradication. Acta Gastroenterol. Belg. 1998; 61: 350 1.
  • 11
    Labenz J. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology. 1997; 112: 1442 7.
  • 12
    Goh KL, Parasakthi N, Cheah PL et al. No occurrence of reflux oesophagitis following Helicobacter pylori eradication in duodenal ulcer patients. A 5-year endoscopic follow-up in South East Asian patients. Gastroenterology 1999; 116: A173 (Abstract).
  • 13
    Talley NJ, Janssens J, Lauritsen K et al. No increase of reflux symptoms in patients with non-ulcer dyspepsia 12 months after Helicobacter pylori eradication. A randomized double-blind placebo-controlled trial. Digestion 1998; 59 (Suppl. 3): 7 (Abstract).
  • 14
    Nehra D, Howell P, Williams CP, Pye JK, Beynon J. Toxic bile acids in gastro-oesophageal reflux disease: Influence of gastric acidity. Gut 1999; 44: 598 602.
  • 15
    Navaratnam RM & Winslet MC. Gastro-oesophageal reflux: The disease of the millennium. Hosp. Med. 1998; 59: 646 9.
  • 16
    Orlando RC. Review article: Oesophageal mucosal resistance. Aliment. Pharmacol. Ther. 1998; 12: 191 7.
  • 17
    Orlando RC. Esophageal epithelial defenses against acid injury. Am. J. Gastroenterol. 1994; 89: S48 52.
  • 18
    Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: Incidence and precipitating factors. Am. J. Dig. Dis. 1976; 21: 953 6.
  • 19
    Sontag SJ. Rolling review: Gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther. 1993; 7: 293 312.
  • 20
    Freston JW, Malagelada JR, Peterson H, McCloy RF. Critical issues in the management of gastroesophageal reflux disease. Eur. J. Gastroenterol. Hepatol. 1995; 7: 577 86.
  • 21
    Papaila J, Wilmot D, Grosfeld J, Rescorla F, West K, Vane D. Increased incidence of delayed gastric emptying in children with gastroesophageal reflux. A prospective evaluation. Arch. Surg. 1989; 124: 933 6.
  • 22
    Maddern GJ, Chatterton BE, Collins PJ, Horowitz M, Schearman DJC, Jamieson GG. Solid and liquid gastric emptying in patients with gastro-oesophageal reflux. Br. J. Surg. 1985; 72: 344 7.
  • 23
    Ollyo JB, Monnier P, Fontolliet C. The natural history, prevalence and incidence of reflux esophagitis. Gullet 1993; 3 (Suppl.): 3 10.
  • 24
    Urschel Jr HC & Paulson DL. Gastroesophageal reflux and hiatal hernia. Complications and therapy. J. Thorac. Cardiovasc. Surg. 1967; 53: 21 32.
  • 25
    Burkitt DP & James PA. Low residue diets and hiatus hernia. Lancet 1973; ii: 128 30.
  • 26
    Ke MY, Wang ZS, Deng FR. Diagnosis and treatment of angina-like chest pain. Chung Hua Nei Ko Tsa Chih 1993; 32: 295 7.
  • 27
    Lau GK, Hui WM, Lau CP, Hu WH, Lai KC, Lam SK. Abnormal gastro-oesophageal reflux in Chinese with atypical chest pain. J. Gastroenterol. Hepatol. 1996; 11: 775 9.
  • 28
    Hu WHC, Hui WM, Lam CLK, Lam SK. Anxiety and depression are co-factors determining health care utilisation in patients with dyspepsia: A Hong Kong population based study. Gastroenterology 1997; 112 (Suppl. 1): A153.
  • 29
    Lee SK, Kim MH, Han DS, Kim JW, Min YI. Epidemiologic study of reflux esophagitis in general health screening people. Kor. J. Intern. Med. 1994; 46: 514 20.
  • 30
    Yeom JS, Park HJ, Cho JS, Lee SI, Park IS. Reflux esophagitis and its relationship of hiatal hernia. J. Kor. Med. Sci. 1999; 14: 253 6.
  • 31
    Kang JY, Tay HH, Yap I, Guan R, Lim KP, Math MV. Low frequency of endoscopic esophagitis in Asian patients. J. Clin. Gastroenterol. 1993; 16: 70 3.
  • 32
    Wang TH, Lai MY, Lin RT et al. Clinical experience with the upper gastrointestinal panendoscope GIF-P (2) (Olympus). Taiwan I Hsueh Hui Tsa Chih 1978; 77: 44 55.
  • 33
    Chang CS, Poon SK, Lien HC, Chen GH. The incidence of reflux esophagitis among the Chinese. Am. J. Gastroenterol. 1997; 92: 668 71.
  • 34
    Spechler SJ & Goyal RK. Barrett’s esophagus. N. Engl. J. Med. 1986; 315: 362 71.
  • 35
    Chen PH. Barrett’s oesophagus in Taiwan. J. Gastroenterol. Hepatol. 1997; 12 (Suppl.): S19 22.
  • 36
    Smout AJ, Lam HG, Breumelhof R. Ambulatory esophageal monitoring in noncardiac chest pain. Am. J. Med. 1992; 92: 74S 80S.
  • 37
    Jones R. Gastro-oesophageal reflux disease in general practice. Scand. J. Gastroenterol. 1995; 211 (Suppl): 35 8.
  • 38
    Hou XH, Xiong Y, Zhang JK. Delayed gastric liquid emptying in the patients with gastroesophageal reflux disease. Chung Hua Nei Ko Tsa Chih 1993; 32: 600 2.
  • 39
    Ireland A, Lyrenas E, Tippett M. Provocation of transient lower esophageal sphincter relaxations and gastroesophageal reflux by intraduodenal fat. Gastroenterology 1990; 98: A361.
  • 40
    Feldman M & Barnett C. Relationships between the acidity and osmolality of popular beverages and reported postprandial heartburn. Gastroenterology 1995; 108: 125 31.
  • 41
    Kahrilas PJ & Gupta RR. The effect of cigarette smoking on salivation and esophageal acid clearance. J. Lab. Clin. Med. 1989; 114: 431 8.
  • 42
    Hogan WJ, Viegas de Andrade SR, Winship DH. Ethanol-induced acute esophageal motor dysfunction. J. Appl. Physiol. 1972; 32: 755 60.
  • 43
    Lam S, Hasan M, Sircus W, Wong J, Ong GB, Prescott RJ. Comparison of maximal acid output and gastrin response to meals in Chinese and Scottish normal and duodenal ulcer subjects. Gut 1980; 21: 324 8.
  • 44
    Mold JW, Reed LE, Davis AB, Allen ML, Decktor DL, Robinson M. Prevalence of gastroesophageal reflux in elderly patients in a primary care setting. Am. J. Gastroenterol. 1991; 86: 965 70.
  • 45
    Dubey P, Sundram KR, Nundy S. Effect of tea on gastric acid secretion. Dig. Dis. Sci. 1984; 29: 202 6.
  • 46
    McCarthy S, Chia YC, Goh KL. Epidemiology of dyspepsia in a primary care unit of a multiracial society. J. Gastroenterol. Hepatol. 1996; 11: A67.
  • 47
    Goh KL. Prevalence of and risk factors for Helicobacter pylori infection in a multi-racial dyspeptic Malaysian population undergoing endoscopy. J. Gastroenterol. Hepatol. 1997; 12: S29 35.
  • 48
    Nebel OT & Castell DO. Lower esophageal sphincter pressure changes after food ingestion. Gastroenterology 1972; 63: 778 83.
  • 49
    Ledeboer M, Masclee AA, Batstra MR, Jansen JB, Lamers CB. Effect of cholecystokinin on lower oesophageal sphincter pressure and transient lower oesophageal sphincter relaxations in humans. Gut 1995; 36: 39 44.
  • 50
    Wilson LJ, Hirschowitz BI, Marks RD. Association of obesity with hiatal hernia and esophagitis. Gastroenterology 1996; 111: A296.
  • 51
    Feldman M, Richardson CT, Lam SK, Samloff IM. Comparison of gastric acid secretion rates and serum pepsinogen I and II concentrations in Occidental and Oriental duodenal ulcer patients. Gastroenterology 1988; 95: 630 5.
  • 52
    Baron JH. Clinical Tests of Gastric Secretion. London: MacMillan, 1978.
  • 53
    Kinoshita Y, Kawanami C, Kishi K, Nakata H, Seino Y, Chiba T. Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese. Gut 1997; 41: 452 8.
  • 54
    El-Serag HB & Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998; 43: 327 33.
  • 55
    Watanabe Y, Ozasa K, Higashi A et al. Helicobacter pylori infection and atrophic gastritis. A case-control study in a rural town of Japan. J. Clin. Gastroenterol. 1997; 25: 391 4.
  • 56
    Haruma K, Okamoto S, Kawaguchi H et al. Reduced incidence of Helicobacter pylori infection in young Japanese persons between the 1970s and the 1990s. J. Clin. Gastroenterol. 1997; 25: 583 6.
  • 57
    Park HJ, Lee JD, Jung JK, Moon BS, Collins PJ, Park IS. The functional relationships between hiatal hernia and reflux esophagitis. Yonsei Med. J. 1996; 37: 278 83.
  • 58
    Newton M, Kamm MA, Quigley T, Burnham WR. Symptomatic gastroesophageal reflux in acutely hospitalized patients. Dig. Dis. Sci. 1999; 44: 140 8.
  • 59
    Wendl B, Pfeiffer A, Pehl C, Schmidt T, Kaess H. Effect of decaffeination of coffee or tea on gastro-oesophageal reflux. Aliment. Pharmacol. Ther. 1994; 8: 283 7.
  • 60
    Klinkenberg-Knol EC, Festen HP, Jansen JB et al. Long-term treatment with omeprazole for refractory reflux esophagitis: Efficacy and safety. Ann. Intern. Med. 1994; 121: 161 7.
  • 61
    Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis. Gastroenterology 1997; 112: 1798 810.
  • 62
    Klinkenberg-Knol EC & Festein HPM. The medical management of gastroesophageal reflux disease. Gastroenterol. Int. 1997; 10: 109 18.
  • 63
    Decktor DL, Robinson M, Maton PN, Rodriquez SL. H2-receptor antagonist tolerance and gastroesophageal reflux disease: A comparison of nizatidine, ranitidine and famotidine on esophageal and gastric pH over 28 days of standard therapy. Am. J. Gastroenterol. 1993; 88: 1487 (Abstract).
  • 64
    Sridhar S, Huang J, O’Brien BJ, Hunt RH. Clinical economics review: Cost-effectiveness of treatment alternatives for gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther. 1996; 10: 865 73.
  • 65
    Fennerty MB. The economics of therapy of gastroesophageal reflux disease. Gastroenterol. Int. 1997; 10: 126 30.
  • 66
    Small PK, Loudon MA, Waldron B, Smith D, Campbell FC. Importance of reflux symptoms in functional dyspepsia. Gut 1995; 36: 189 92.
  • 67
    Fisher RS & Parkman HP. Management of nonulcer dyspepsia. N. Engl. J. Med. 1998; 339: 1376 81.
  • 68
    Bardhan KD. Is there any acid peptic disease that is refractory to proton pump inhibitors? Aliment. Pharmacol. Ther. 1993; 7 (Suppl. 1): 13 24.
  • 69
    Tytgat GN. The clinical use of cisapride in gastro-oesophageal reflux disease, with particular focus on the long-term treatment aspects. Scand. J. Gastroenterol. 1995; 211 (Suppl.): 39 43.
  • 70
    Vigneri S, Termini R, Leandro G et al. A comparison of five maintenance therapies for reflux esophagitis. N. Engl. J. Med. 1995; 333: 1106 10.
  • 71
    Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, eds. Cancer Incidence in Five Continents. Lyon: IARC Scientific Publications, 1997.